Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
The inducement grants are subject to the terms and conditions of award agreements covering the grants and the company\xe2\x80\x99s 2021 Inducement Equity Incentive Plan.\nSchr\xc3\xb6dinger is transforming the way therapeutics and materials are discovered.
- The inducement grants are subject to the terms and conditions of award agreements covering the grants and the company\xe2\x80\x99s 2021 Inducement Equity Incentive Plan.\nSchr\xc3\xb6dinger is transforming the way therapeutics and materials are discovered.
- Schr\xc3\xb6dinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods.
- The software platform is used by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world.
- To learn more, visit www.schrodinger.com and follow us on LinkedIn and Twitter.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210519005108/en/\n'